Raymond James lowered the firm’s price target on Integral Ad Science (IAS) to $11 from $16 and keeps an Outperform rating on the shares. The firm’s checks suggest that the ad industry had held up “pretty well” in Q1, with “largely positive” economic conditions through March and consumer health perceptions supported a solid ad backdrop, the analyst tells investors in a research note. While the firm expects solid Q1 results, Raymond James expects a guidance reiteration, not raise, given reduced visibility.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IAS:
- Integral Ad Science price target lowered to $13 from $15 at Stifel
- Integral Ad Science price target lowered to $7 from $14 at Barclays
- Integral Ad Science price target lowered to $12.50 from $13.50 at Morgan Stanley
- Integral Ad Science, Reddit expand partnership
- IAS Lawsuit Alert! Class Action Lawsuit Against Integral Ad Science Holding Corp.